Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 11.466
1.
Plant Physiol Biochem ; 210: 108631, 2024 May.
Article En | MEDLINE | ID: mdl-38657550

Glutamine synthetase (GS), an initial enzyme in nitrogen (N) plant metabolism, exists as a group of isoenzymes found in both cytosolic (GS1) and plastids (GS2) and has gathered significant attention for enhancing N use efficiency and crop yield. This work focuses on the A. thaliana GLN1;3 and GLN1;5 genes, the two predicted most expressed genes in seeds, among the five isogenes encoding GS1 in this species. The expression patterns were studied using transgenic marker line plants and qPCR during seed development and germination. The observed patterns highlight distinct functions for the two genes and confirm GLN1;5 as the most highly expressed GS1 gene in seeds. The GLN1;5, expression, oriented towards hypocotyl and cotyledons, suggests a role in protein turnover during germination, while the radicle-oriented expression of GLN1;3 supports a function in early external N uptake. While the single mutants exhibited a normal phenotype, except for a decrease in seed parameters, the double gln1;3/gln1;5 mutant displayed a germination delay, substantial impairment in growth, nitrogen metabolism, and number and quality of the seeds, as well as a diminishing in flowering. Although seed and pollen-specific, GLN1;5 expression is upregulated in the meristems of the gln1;3 mutants, filling the lack of GLN1;3 and ensuring the normal functioning of the gln1;3 mutants. These findings validate earlier in silico data on the expression patterns of GLN1;3 and GL1;5 genes in seeds, explore their different functions, and underscore their essential role in plant growth, seed production, germination, and early stages of plant development.


Arabidopsis Proteins , Arabidopsis , Gene Expression Regulation, Plant , Germination , Glutamate-Ammonia Ligase , Seeds , Arabidopsis/genetics , Arabidopsis/growth & development , Arabidopsis/enzymology , Seeds/growth & development , Seeds/genetics , Seeds/enzymology , Germination/genetics , Glutamate-Ammonia Ligase/genetics , Glutamate-Ammonia Ligase/metabolism , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Cytosol/enzymology , Cytosol/metabolism , Nitrogen/metabolism , Plants, Genetically Modified , Isoenzymes/genetics , Isoenzymes/metabolism
2.
Nat Cell Biol ; 24(2): 205-216, 2022 02.
Article En | MEDLINE | ID: mdl-35145225

METTL16 has recently been identified as an RNA methyltransferase responsible for the deposition of N6-methyladenosine (m6A) in a few transcripts. Whether METTL16 methylates a large set of transcripts, similar to METTL3 and METTL14, remains unclear. Here we show that METTL16 exerts both methyltransferase activity-dependent and -independent functions in gene regulation. In the cell nucleus, METTL16 functions as an m6A writer to deposit m6A into hundreds of its specific messenger RNA targets. In the cytosol, METTL16 promotes translation in an m6A-independent manner. More specifically, METTL16 directly interacts with the eukaryotic initiation factors 3a and -b as well as ribosomal RNA through its Mtase domain, thereby facilitating the assembly of the translation-initiation complex and promoting the translation of over 4,000 mRNA transcripts. Moreover, we demonstrate that METTL16 is critical for the tumorigenesis of hepatocellular carcinoma. Collectively, our studies reveal previously unappreciated dual functions of METTL16 as an m6A writer and a translation-initiation facilitator, which together contribute to its essential function in tumorigenesis.


Adenosine/analogs & derivatives , Carcinogenesis/metabolism , Carcinoma, Hepatocellular/enzymology , Liver Neoplasms/enzymology , Methyltransferases/metabolism , Protein Biosynthesis , RNA Processing, Post-Transcriptional , RNA, Messenger/metabolism , Adenosine/metabolism , Animals , Carcinogenesis/genetics , Carcinogenesis/pathology , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Cytosol/enzymology , Eukaryotic Initiation Factor-3/genetics , Eukaryotic Initiation Factor-3/metabolism , Gene Expression Regulation, Neoplastic , HEK293 Cells , Hep G2 Cells , Humans , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Methyltransferases/genetics , Mice, Inbred NOD , Mice, SCID , RNA, Messenger/genetics , RNA, Ribosomal/genetics , RNA, Ribosomal/metabolism , Signal Transduction , Tumor Burden
3.
Viruses ; 14(2)2022 01 25.
Article En | MEDLINE | ID: mdl-35215835

During infection with dengue viruses (DENVs), the lipid landscape within host cells is significantly altered to assemble membrane platforms that support viral replication and particle assembly. Fatty acyl-CoAs are key intermediates in the biosynthesis of complex lipids that form these membranes. They also function as key signaling lipids in the cell. Here, we carried out loss of function studies on acyl-CoA thioesterases (ACOTs), a family of enzymes that hydrolyze fatty acyl-CoAs to free fatty acids and coenzyme A, to understand their influence on the lifecycle of DENVs. The loss of function of the type I ACOTs 1 (cytoplasmic) and 2 (mitochondrial) together significantly increased DENV serotype 2 (DENV2) viral replication and infectious particle release. However, isolated knockdown of mitochondrial ACOT2 significantly decreased DENV2 protein translation, genome replication, and infectious virus release. Furthermore, loss of ACOT7 function, a mitochondrial type II ACOT, similarly suppressed DENV2. As ACOT1 and ACOT2 are splice variants, these data suggest that functional differences and substrate specificities due to the location (cytosol and mitochondria, respectively) of these proteins may account for the differences in DENV2 infection phenotype. Additionally, loss of mitochondrial ACOT2 and ACOT7 expression also altered the expression of several ACOTs located in multiple organelle compartments within the cell, highlighting a complex relationship between ACOTs in the DENV2 virus lifecycle.


Dengue Virus/physiology , Fatty Acids/metabolism , Palmitoyl-CoA Hydrolase/metabolism , Thiolester Hydrolases/metabolism , Animals , Cell Line , Cell Line, Tumor , Cytosol/enzymology , Dengue Virus/genetics , Gene Knockdown Techniques , Genome, Viral , Humans , Mitochondria/enzymology , Palmitoyl-CoA Hydrolase/genetics , RNA, Small Interfering , Thiolester Hydrolases/genetics , Virus Release , Virus Replication
4.
Ann Bot ; 129(1): 37-52, 2022 01 08.
Article En | MEDLINE | ID: mdl-34549262

BACKGROUND AND AIMS: ATP-dependent phosphofructokinases (PFKs) catalyse phosphorylation of the carbon-1 position of fructose-6-phosphate, to form fructose-1,6-bisphosphate. In the cytosol, this is considered a key step in channelling carbon into glycolysis. Arabidopsis thaliana has seven genes encoding PFK isoforms, two chloroplastic and five cytosolic. This study focuses on the four major cytosolic isoforms of PFK in vegetative tissues of A. thaliana. METHODS: We isolated homozygous knockout individual mutants (pfk1, pfk3, pfk6 and pfk7) and two double mutants (pfk1/7 and pfk3/6), and characterized their growth and metabolic phenotypes. KEY RESULTS: In contrast to single mutants and the double mutant pfk3/6 for the hypoxia-responsive isoforms, the double mutant pfk1/7 had reduced PFK activity and showed a clear visual and metabolic phenotype with reduced shoot growth, early flowering and elevated hexose levels. This mutant also has an altered ratio of short/long aliphatic glucosinolates and an altered root-shoot distribution. Surprisingly, this mutant does not show any major changes in short-term carbon flux and in levels of hexose-phosphates. CONCLUSIONS: We conclude that the two isoforms PFK1 and PFK7 are important for sugar homeostasis in leaf metabolism and apparently in source-sink relationships in A. thaliana, while PFK3 and PFK6 only play a minor role under normal growth conditions.


Arabidopsis , Phosphofructokinases , Plant Leaves/enzymology , Sugars , Arabidopsis/enzymology , Arabidopsis/genetics , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Cytosol/enzymology , Homeostasis , Phosphofructokinases/genetics , Phosphofructokinases/metabolism , Sugars/metabolism
5.
PLoS Negl Trop Dis ; 15(11): e0009951, 2021 11.
Article En | MEDLINE | ID: mdl-34780470

With current drug treatments failing due to toxicity, low efficacy and resistance; leishmaniasis is a major global health challenge that desperately needs new validated drug targets. Inspired by activity of the natural chalcone 2',6'-dihydroxy-4'-methoxychalcone (DMC), the nitro-analogue, 3-nitro-2',4',6'- trimethoxychalcone (NAT22, 1c) was identified as potent broad spectrum antileishmanial drug lead. Structural modification provided an alkyne containing chemical probe that labelled a protein within the parasite that was confirmed as cytosolic tryparedoxin peroxidase (cTXNPx). Crucially, labelling is observed in both promastigote and intramacrophage amastigote life forms, with no evidence of host macrophage toxicity. Incubation of the chalcone in the parasite leads to ROS accumulation and parasite death. Deletion of cTXNPx, by CRISPR-Cas9, dramatically impacts upon the parasite phenotype and reduces the antileishmanial activity of the chalcone analogue. Molecular docking studies with a homology model of in-silico cTXNPx suggest that the chalcone is able to bind in the putative active site hindering access to the crucial cysteine residue. Collectively, this work identifies cTXNPx as an important target for antileishmanial chalcones.


Antiprotozoal Agents/therapeutic use , Chalcone/metabolism , Chalcone/pharmacology , Cytosol/drug effects , Leishmania/drug effects , Peroxidases/antagonists & inhibitors , Protozoan Proteins/antagonists & inhibitors , Animals , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/pharmacology , Cells, Cultured , Chalcone/administration & dosage , Chalcone/analogs & derivatives , Cytosol/enzymology , Cytosol/parasitology , Drug Discovery , Humans , Leishmania/classification , Leishmaniasis/drug therapy , Leishmaniasis/parasitology , Macrophages/drug effects , Macrophages/parasitology , Mice , Mice, Inbred BALB C , Molecular Docking Simulation , Peroxidases/metabolism , Protozoan Proteins/metabolism
6.
Biomolecules ; 11(9)2021 09 09.
Article En | MEDLINE | ID: mdl-34572542

Maintaining iron homeostasis is fundamental for almost all living beings, and its deregulation correlates with severe and debilitating pathologies. The process is made more complicated by the omnipresence of iron and by its role as a fundamental component of a number of crucial metallo proteins. The response to modifications in the amount of the free-iron pool is performed via the inhibition of ferritin translation by sequestering consensus messenger RNA (mRNA) sequences. In turn, this is regulated by the iron-sensitive conformational equilibrium between cytosolic aconitase and IRP1, mediated by the presence of an iron-sulfur cluster. In this contribution, we analyze by full-atom molecular dynamics simulation, the factors leading to both the interaction with mRNA and the conformational transition. Furthermore, the role of the iron-sulfur cluster in driving the conformational transition is assessed by obtaining the related free energy profile via enhanced sampling molecular dynamics simulations.


Aconitate Hydratase/metabolism , Cytosol/enzymology , Ferritins/metabolism , Hemostasis , Iron-Regulatory Proteins/metabolism , Iron/metabolism , Protein Biosynthesis , Aconitate Hydratase/chemistry , Animals , Chickens , Humans , Iron-Regulatory Proteins/chemistry , Molecular Dynamics Simulation , RNA, Messenger/genetics , RNA, Messenger/metabolism , Thermodynamics , Time Factors
7.
Nucleic Acids Res ; 49(16): 9389-9403, 2021 09 20.
Article En | MEDLINE | ID: mdl-34387695

Cyclic GMP-AMP synthase (cGAS) is a key DNA sensor that detects aberrant cytosolic DNA arising from pathogen invasions or genotoxic stresses. Upon binding to DNA, cGAS is activated and catalyzes the synthesis of cyclic GMP-AMP (cGAMP), which induces potent antimicrobial and antitumor responses. Kaposi sarcoma-associated herpesvirus (KSHV) is a human DNA tumor virus that causes Kaposi sarcoma and several other malignancies. We previously reported that KSHV inhibitor of cGAS (KicGAS) encoded by ORF52, inhibits cGAS enzymatic activity, but the underlying mechanisms remained unclear. To define the inhibitory mechanisms, here we performed in-depth biochemical and functional characterizations of KicGAS, and mapped its functional domains. We found KicGAS self-oligomerizes and binds to double stranded DNA cooperatively. This self-oligomerization is essential for its DNA binding and cGAS inhibition. Interestingly, KicGAS forms liquid droplets upon binding to DNA, which requires collective multivalent interactions with DNA mediated by both structured and disordered domains coordinated through the self-oligomerization of KicGAS. We also observed that KicGAS inhibits the DNA-induced phase separation and activation of cGAS. Our findings reveal a novel mechanism by which DNA viruses target the host protein phase separation for suppression of the host sensing of viral nucleic acids.


Herpesvirus 8, Human/genetics , Host-Pathogen Interactions/genetics , Nucleotidyltransferases/genetics , Sarcoma, Kaposi/genetics , Cytosol/enzymology , Cytosol/microbiology , DNA Breaks, Double-Stranded/drug effects , DNA Damage/genetics , DNA, Viral/genetics , DNA-Binding Proteins/genetics , Herpesvirus 8, Human/pathogenicity , Humans , Immune Evasion/drug effects , Immunity, Innate/genetics , Nucleotides, Cyclic/genetics , Nucleotidyltransferases/antagonists & inhibitors , Sarcoma, Kaposi/drug therapy , Sarcoma, Kaposi/virology , Viral Proteins/genetics
8.
Physiol Rep ; 9(17): e15003, 2021 09.
Article En | MEDLINE | ID: mdl-34435451

Myosin, the most abundant myofibrillar protein in skeletal muscle, functions as a motor protein in muscle contraction. Myosin polymerizes into the thick filaments in the sarcomere where approximately 50% of embryonic myosin (Myh3) are replaced within 3 h (Ojima K, Ichimura E, Yasukawa Y, Wakamatsu J, Nishimura T, Am J Physiol Cell Physiol 309: C669-C679, 2015). The sarcomere structure including the thick filament is maintained by a balance between protein biosynthesis and degradation. However, the involvement of a protein degradation system in the myosin replacement process remains unclear. Here, we show that the muscle-specific ubiquitin ligase Ozz regulates replacement rate of Myh3. To examine the direct effect of Ozz on myosin replacement, eGFP-Myh3 replacement rate was measured in myotubes overexpressing Ozz by fluorescence recovery after photobleaching. Ozz overexpression significantly decreased the replacement rate of eGFP-Myh3 in the myofibrils, whereas it had no effect on other myosin isoforms. It is likely that ectopic Ozz promoted myosin degradation through increment of ubiquitinated myosin, and decreased myosin supply for replacement, thereby reducing myosin replacement rate. Intriguingly, treatment with a proteasome inhibitor MG132 also decreased myosin replacement rate, although MG132 enhanced the accumulation of ubiquitinated myosin in the cytosol where replaceable myosin is pooled, suggesting that ubiquitinated myosin is not replaced by myosin in the myofibril. Collectively, our findings showed that Myh3 replacement rate was reduced in the presence of overexpressed Ozz probably through enhanced ubiquitination and degradation of Myh3 by Ozz.


Embryo, Nonmammalian/enzymology , Muscle Proteins/biosynthesis , Myofibrils/enzymology , Myosins/biosynthesis , Ubiquitin-Protein Ligase Complexes/biosynthesis , Animals , Cells, Cultured , Chick Embryo , Cytosol/enzymology , Myosins/antagonists & inhibitors
9.
J Biol Chem ; 297(4): 101110, 2021 10.
Article En | MEDLINE | ID: mdl-34428448

Valproate (VPA) is a widely used mood stabilizer, but its therapeutic mechanism of action is not understood. This knowledge gap hinders the development of more effective drugs with fewer side effects. Using the yeast model to elucidate the effects of VPA on cellular metabolism, we determined that the drug upregulated expression of genes normally repressed during logarithmic growth on glucose medium and increased levels of activated (phosphorylated) Snf1 kinase, the major metabolic regulator of these genes. VPA also decreased the cytosolic pH (pHc) and reduced glycolytic production of 2/3-phosphoglycerate. ATP levels and mitochondrial membrane potential were increased, and glucose-mediated extracellular acidification decreased in the presence of the drug, as indicated by a smaller glucose-induced shift in pH, suggesting that the major P-type proton pump Pma1 was inhibited. Interestingly, decreasing the pHc by omeprazole-mediated inhibition of Pma1 led to Snf1 activation. We propose a model whereby VPA lowers the pHc causing a decrease in glycolytic flux. In response, Pma1 is inhibited and Snf1 is activated, resulting in increased expression of normally repressed metabolic genes. These findings suggest a central role for pHc in regulating the metabolic program of yeast cells.


Cytosol/enzymology , Protein Serine-Threonine Kinases/metabolism , Saccharomyces cerevisiae/enzymology , Valproic Acid/pharmacology , Adenosine Triphosphate/genetics , Adenosine Triphosphate/metabolism , Enzyme Activation/drug effects , Enzyme Activation/genetics , Glycolysis/drug effects , Glycolysis/genetics , Hydrogen-Ion Concentration , Protein Serine-Threonine Kinases/genetics , Proton-Translocating ATPases/genetics , Proton-Translocating ATPases/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism
10.
Int J Mol Sci ; 22(11)2021 Jun 02.
Article En | MEDLINE | ID: mdl-34199464

The influence of salt stress on gene expression, promoter methylation, and enzymatic activity of the mitochondrial and cytosolic forms of aconitase and fumarase has been investigated in maize (Zea mays L.) seedlings. The incubation of maize seedlings in 150-mM NaCl solution resulted in a several-fold increase of the mitochondrial activities of aconitase and fumarase that peaked at 6 h of NaCl treatment, while the cytosolic activity of aconitase and fumarase decreased. This corresponded to the decrease in promoter methylation of the genes Aco1 and Fum1 encoding the mitochondrial forms of these enzymes and the increase in promoter methylation of the genes Aco2 and Fum2 encoding the cytosolic forms. The pattern of expression of the genes encoding the mitochondrial forms of aconitase and fumarase corresponded to the profile of the increase of the stress marker gene ZmCOI6.1. It is concluded that the mitochondrial and cytosolic forms of aconitase and fumarase are regulated via the epigenetic mechanism of promoter methylation of their genes in the opposite ways in response to salt stress. The role of the mitochondrial isoforms of aconitase and fumarase in the elevation of respiration under salt stress is discussed.


Aconitate Hydratase/genetics , DNA Methylation/genetics , Fumarate Hydratase/genetics , Salt Stress/genetics , Cytosol/enzymology , Gene Expression Regulation, Plant/genetics , Mitochondria/enzymology , Promoter Regions, Genetic/genetics , Zea mays/genetics , Zea mays/growth & development
11.
RNA Biol ; 18(12): 2605-2616, 2021 12.
Article En | MEDLINE | ID: mdl-34039240

Aminoacyl-tRNA synthetases (aaRSs) are a conserved family of enzymes with an essential role in protein synthesis: ligating amino acids to cognate tRNA molecules for translation. In addition to their role in tRNA charging, aaRSs have acquired non-canonical functions, including post-transcriptional regulation of mRNA expression. Yet, the extent and mechanisms of these post-transcriptional functions are largely unknown. Herein, we performed a comprehensive transcriptome analysis to define the mRNAs that are associated with almost all aaRSs present in S. cerevisiae cytosol. Nineteen (out of twenty) isogenic strains of GFP-tagged cytosolic aaRSs were subjected to immunoprecipitation with anti-GFP beads along with an untagged control. mRNAs associated with each aaRS were then identified by RNA-seq. The extent of mRNA association varied significantly between aaRSs, from MetRS in which none appeared to be statistically significant, to PheRS that binds hundreds of different mRNAs. Interestingly, many target mRNAs are bound by multiple aaRSs, suggesting co-regulation by this family of enzymes. Gene Ontology analyses for aaRSs with a considerable number of target mRNAs discovered an enrichment for pathways of amino acid metabolism and of ribosome biosynthesis. Furthermore, sequence and structure motif analysis revealed for some aaRSs an enrichment for motifs that resemble the anticodon stem loop of cognate tRNAs. These data suggest that aaRSs coordinate mRNA expression in response to amino acid availability and may utilize RNA elements that mimic their canonical tRNA binding partners.


Amino Acyl-tRNA Synthetases/metabolism , Cytosol/enzymology , Gene Expression Regulation, Fungal , RNA, Messenger/metabolism , RNA, Transfer/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Amino Acyl-tRNA Synthetases/genetics , RNA, Messenger/genetics , RNA, Transfer/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics
12.
Toxicol Appl Pharmacol ; 425: 115553, 2021 08 15.
Article En | MEDLINE | ID: mdl-33915121

p-Cresol sulfate, the primary metabolite of p-cresol, is a uremic toxin that has been associated with toxicities and mortalities. The study objectives were to i) characterize the contributions of human sulfotransferases (SULT) catalyzing p-cresol sulfate formation using multiple recombinant SULT enzymes (including the polymorphic variant SULT1A1*2), pooled human liver cytosols, and pooled human kidney cytosols; and ii) determine the potencies and mechanisms of therapeutic inhibitors capable of attenuating the production of p-cresol sulfate. Human recombinant SULT1A1 was the primary enzyme responsible for the formation of p-cresol sulfate (Km = 0.19 ±â€¯0.02 µM [with atypical kinetic behavior at lower substrate concentrations; see text discussion], Vmax = 789.5 ±â€¯101.7 nmol/mg/min, Ksi = 2458.0 ±â€¯332.8 µM, mean ±â€¯standard deviation, n = 3), while SULT1A3, SULT1B1, SULT1E1, and SULT2A1 contributed negligible or minor roles at toxic p-cresol concentrations. Moreover, human recombinant SULT1A1*2 exhibited reduced enzyme activities (Km = 81.5 ±â€¯31.4 µM, Vmax = 230.6 ±â€¯17.7 nmol/mg/min, Ksi = 986.0 ±â€¯434.4 µM) compared to the wild type. The sulfonation of p-cresol was characterized by Michaelis-Menten kinetics in liver cytosols (Km = 14.8 ±â€¯3.4 µM, Vmax = 1.5 ±â€¯0.2 nmol/mg/min) and substrate inhibition in kidney cytosols (Km = 0.29 ±â€¯0.02 µM, Vmax = 0.19 ±â€¯0.05 nmol/mg/min, Ksi = 911.7 ±â€¯278.4 µM). Of the 14 investigated therapeutic inhibitors, mefenamic acid (Ki = 2.4 ±â€¯0.1 nM [liver], Ki = 1.2 ±â€¯0.3 nM [kidney]) was the most potent in reducing the formation of p-cresol sulfate, exhibiting noncompetitive inhibition in human liver cytosols and recombinant SULT1A1, and mixed inhibition in human kidney cytosols. Our novel findings indicated that SULT1A1 contributed an important role in p-cresol sulfonation (hence it can be considered a probe reaction) in liver and kidneys, and mefenamic acid may be utilized as a potential therapeutic agent to attenuate the generation of p-cresol sulfate as an approach to detoxification.


Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cresols/metabolism , Cresols/toxicity , Mefenamic Acid/pharmacology , Sulfotransferases/metabolism , Sulfuric Acid Esters/metabolism , Sulfuric Acid Esters/toxicity , Catalysis , Cytosol/enzymology , Humans , Kidney , Liver , Recombinant Proteins , Sulfotransferases/antagonists & inhibitors , Sulfotransferases/genetics
13.
Biosci Biotechnol Biochem ; 85(6): 1460-1463, 2021 May 25.
Article En | MEDLINE | ID: mdl-33724383

Cytosolic peptide:N-glycanase (cPNGase), which occurs ubiquitously in eukaryotic cells, is involved in the de-N-glycosylation of misfolded glycoproteins in the protein quality control system. In this study, we aimed to provide direct evidence of plant cPNGase activity against a denatured glycoprotein using a crude extract prepared from a mutant line of Arabidopsis thaliana lacking 2 acidic PNGase genes.


Arabidopsis/enzymology , Cytosol/enzymology , Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase/metabolism , Arabidopsis/cytology , Arabidopsis/genetics , Glycosylation , Mutation , Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase/genetics
14.
Sci Rep ; 11(1): 2854, 2021 02 03.
Article En | MEDLINE | ID: mdl-33536500

The Plasmodium falciparum M1 alanyl aminopeptidase and M17 leucyl aminopeptidase, PfM1AAP and PfM17LAP, are potential targets for novel anti-malarial drug development. Inhibitors of these aminopeptidases have been shown to kill malaria parasites in culture and reduce parasite growth in murine models. The two enzymes may function in the terminal stages of haemoglobin digestion, providing free amino acids for protein synthesis by the rapidly growing intra-erythrocytic parasites. Here we have performed a comparative cellular and biochemical characterisation of the two enzymes. Cell fractionation and immunolocalisation studies reveal that both enzymes are associated with the soluble cytosolic fraction of the parasite, with no evidence that they are present within other compartments, such as the digestive vacuole (DV). Enzyme kinetic studies show that the optimal pH of both enzymes is in the neutral range (pH 7.0-8.0), although PfM1AAP also possesses some activity (< 20%) at the lower pH range of 5.0-5.5. The data supports the proposal that PfM1AAP and PfM17LAP function in the cytoplasm of the parasite, likely in the degradation of haemoglobin-derived peptides generated in the DV and transported to the cytosol.


CD13 Antigens/metabolism , Leucyl Aminopeptidase/metabolism , Plasmodium falciparum/enzymology , Protozoan Proteins/metabolism , Animals , Antimalarials/pharmacology , Antimalarials/therapeutic use , CD13 Antigens/antagonists & inhibitors , CD13 Antigens/chemistry , CD13 Antigens/isolation & purification , Cell Fractionation , Cells, Cultured , Cytosol/enzymology , Drug Development , Enzyme Assays , Erythrocytes/parasitology , Humans , Hydrogen-Ion Concentration , Leucyl Aminopeptidase/antagonists & inhibitors , Leucyl Aminopeptidase/chemistry , Leucyl Aminopeptidase/isolation & purification , Malaria, Falciparum/drug therapy , Malaria, Falciparum/parasitology , Plasmodium falciparum/drug effects , Protozoan Proteins/antagonists & inhibitors , Protozoan Proteins/chemistry , Protozoan Proteins/isolation & purification , Rabbits , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification
15.
Food Chem ; 347: 128973, 2021 Jun 15.
Article En | MEDLINE | ID: mdl-33444888

To improve the crop yield and quality, the cytosolic fructose-1,6-bisphosphatase (cFBPase) from mung bean (Vigna radiata), a rate-limiting enzyme in gluconeogenesis, was cloned, purified, and structurally characterised. To function it required Mg2+ and Mn2+ at 0.01-10 mM. The Michaelis-Menton constant and adenosine monophosphate (AMP) inhibitory constant (Ki) were 7.96 and 111.09 µM, respectively. The functional site residues of AMP binding (Arg30, Asp32, and Phe33) and the active site residues (Asn218 and Met251) were tested via site-directed mutagenesis and molecular docking. Asn218 and Met251 were replaced by Tyr and Leu, respectively. The M251L mutant showed enhanced substrate affinity and activity, resulting from decreased binding energy (-2.58 kcal·mol-1) and molecular distance (4.2 Å). AMP binding site mutations changed the enzyme activities, indicating a connection between the binding and active sites. Furthermore, Ki and docking analysis revealed that Asp32 plays a key role in maintaining the AMP binding conformation.


Cytosol/enzymology , Fructose-Bisphosphatase/genetics , Fructose-Bisphosphatase/isolation & purification , Vigna/enzymology , Vigna/genetics , Adenosine Monophosphate/metabolism , Animals , Binding Sites , Cloning, Molecular , Fructose-Bisphosphatase/chemistry , Fructose-Bisphosphatase/metabolism , Kinetics , Molecular Docking Simulation , Mutagenesis, Site-Directed , Vigna/cytology
16.
Molecules ; 26(2)2021 Jan 12.
Article En | MEDLINE | ID: mdl-33445584

Glucose 6-phosphate dehydrogenase (G6PDH) fulfills an essential role in cell physiology by catalyzing the production of NADPH+ and of a precursor for the de novo synthesis of ribose 5-phosphate. In trypanosomatids, G6PDH is essential for in vitro proliferation, antioxidant defense and, thereby, drug resistance mechanisms. So far, 16α-brominated epiandrosterone represents the most potent hit targeting trypanosomal G6PDH. Here, we extended the investigations on this important drug target and its inhibition by using a small subset of androstane derivatives. In Trypanosoma cruzi, immunofluorescence revealed a cytoplasmic distribution of G6PDH and the absence of signal in major organelles. Cytochemical assays confirmed parasitic G6PDH as the molecular target of epiandrosterone. Structure-activity analysis for a set of new (dehydro)epiandrosterone derivatives revealed that bromination at position 16α of the cyclopentane moiety yielded more potent T. cruzi G6PDH inhibitors than the corresponding ß-substituted analogues. For the 16α brominated compounds, the inclusion of an acetoxy group at position 3 either proved detrimental or enhanced the activity of the epiandrosterone or the dehydroepiandrosterone derivatives, respectively. Most derivatives presented single digit µM EC50 against infective T. brucei and the killing mechanism involved an early thiol-redox unbalance. This data suggests that infective African trypanosomes lack efficient NADPH+-synthesizing pathways, beyond the Pentose Phosphate, to maintain thiol-redox homeostasis.


Glucosephosphate Dehydrogenase/metabolism , Life Cycle Stages , Steroids/pharmacology , Trypanosoma brucei brucei/enzymology , Trypanosoma brucei brucei/growth & development , Androsterone/chemistry , Androsterone/pharmacology , Binding Sites , Cytosol/enzymology , Dehydroepiandrosterone/chemistry , Dehydroepiandrosterone/pharmacology , Glucosephosphate Dehydrogenase/antagonists & inhibitors , Glucosephosphate Dehydrogenase/chemistry , Humans , Life Cycle Stages/drug effects , Models, Molecular , Oxidation-Reduction , Reproducibility of Results , Trypanosoma brucei brucei/drug effects
17.
Nat Commun ; 12(1): 343, 2021 01 12.
Article En | MEDLINE | ID: mdl-33436639

The inhibition of Plasmodium cytosolic phenylalanine tRNA-synthetase (cFRS) by a novel series of bicyclic azetidines has shown the potential to prevent malaria transmission, provide prophylaxis, and offer single-dose cure in animal models of malaria. To date, however, the molecular basis of Plasmodium cFRS inhibition by bicyclic azetidines has remained unknown. Here, we present structural and biochemical evidence that bicyclic azetidines are competitive inhibitors of L-Phe, one of three substrates required for the cFRS-catalyzed aminoacylation reaction that underpins protein synthesis in the parasite. Critically, our co-crystal structure of a PvcFRS-BRD1389 complex shows that the bicyclic azetidine ligand binds to two distinct sub-sites within the PvcFRS catalytic site. The ligand occupies the L-Phe site along with an auxiliary cavity and traverses past the ATP binding site. Given that BRD1389 recognition residues are conserved amongst apicomplexan FRSs, this work lays a structural framework for the development of drugs against both Plasmodium and related apicomplexans.


Azetidines/pharmacology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Malaria/enzymology , Parasites/enzymology , Phenylalanine-tRNA Ligase/antagonists & inhibitors , Phenylalanine-tRNA Ligase/chemistry , Plasmodium falciparum/enzymology , Amino Acid Sequence , Aminoacylation , Animals , Catalytic Domain , Cytosol/enzymology , Drug Resistance/genetics , Models, Molecular , Mutation/genetics , Phenylalanine/metabolism , Phenylalanine-tRNA Ligase/metabolism , Plasmodium falciparum/drug effects
18.
mBio ; 12(1)2021 01 26.
Article En | MEDLINE | ID: mdl-33500339

Toxoplasma gondii is an intracellular protozoan parasite that has the remarkable ability to infect and replicate in neutrophils, immune cells with an arsenal of antimicrobial effector mechanisms. We report that T. gondii infection extends the life span of primary human peripheral blood neutrophils by delaying spontaneous apoptosis, serum starvation-induced apoptosis, and tumor necrosis alpha (TNF-α)-mediated apoptosis. T. gondii blockade of apoptosis was associated with an inhibition of processing and activation of the apoptotic caspases caspase-8 and -3, decreased phosphatidylserine exposure on the plasma membrane, and reduced cell death. We performed a global transcriptome analysis of T. gondii-infected peripheral blood neutrophils using RNA sequencing (RNA-Seq) and identified gene expression changes associated with DNA replication and DNA repair pathways, which in mature neutrophils are indicative of changes in regulators of cell survival. Consistent with the RNA-Seq data, T. gondii infection upregulated transcript and protein expression of PCNA, which is found in the cytosol of human neutrophils, where it functions as a key inhibitor of apoptotic pro-caspases. Infection of neutrophils resulted in increased interaction of PCNA with pro-caspase-3. Inhibition of this interaction with an AlkB homologue 2 PCNA-interacting motif (APIM) peptide reversed the infection-induced delay in cell death. Taken together, these findings indicate a novel strategy by which T. gondii manipulates cell life span in primary human neutrophils, which may allow the parasite to maintain an intracellular replicative niche and avoid immune clearance.IMPORTANCEToxoplasma gondii is an obligate intracellular parasite that can cause life-threatening disease in immunocompromised individuals and in the developing fetus. Interestingly, T. gondii has evolved strategies to successfully manipulate the host immune system to establish a productive infection and evade host defense mechanisms. Although it is well documented that neutrophils are mobilized during acute T. gondii infection and infiltrate the site of infection, these cells can also be actively infected by T. gondii and serve as a replicative niche for the parasite. However, there is a limited understanding of the molecular processes occurring within T. gondii-infected neutrophils. This study reveals that T. gondii extends the life span of human neutrophils by inducing the expression of PCNA, which prevents activation of apoptotic caspases, thus delaying apoptosis. This strategy may allow the parasite to preserve its replicative intracellular niche.


Apoptosis/immunology , Caspase 8/metabolism , Caspases/metabolism , Cytosol/metabolism , Neutrophils/parasitology , Proliferating Cell Nuclear Antigen/genetics , Toxoplasma/immunology , Caspase 3/genetics , Caspase 3/metabolism , Caspase 8/genetics , Caspases/genetics , Cell Survival/immunology , Cells, Cultured , Cytosol/enzymology , Cytosol/parasitology , Gene Expression Profiling , Humans , Neutrophils/enzymology , Neutrophils/physiology , Sequence Analysis, RNA , Up-Regulation
19.
Int J Mol Sci ; 22(2)2021 Jan 16.
Article En | MEDLINE | ID: mdl-33467001

Sucrose synthase is a key enzyme in sucrose metabolism as it saves an important part of sucrose energy in the uridine-5'-diphosphate glucose (UDP-glucose) molecule. As such it is also involved in the synthesis of fundamental molecules such as callose and cellulose, the latter being present in all cell walls of plant cells and therefore also in the gelatinous cell walls of sclerenchyma cells such as bast fibers. Given the importance of these cells in plants of economic interest such as hemp, flax and nettle, in this work we have studied the occurrence of Sucrose synthase in nettle stems by analyzing its distribution between the cytosol, membranes and cell wall. We have therefore developed a purification protocol that can allow the analysis of various characteristics of the enzyme. In nettle, Sucrose synthase is encoded by different genes and each form of the enzyme could be subjected to different post-translational modifications. Therefore, by two-dimensional electrophoresis analysis, we have also traced the phosphorylation profile of Sucrose synthase isoforms in the various cell compartments. This information paves the way for further investigation of Sucrose synthase in plants such as nettle, which is both economically important, but also difficult to study.


Glucosyltransferases/metabolism , Plant Proteins/metabolism , Urtica dioica/enzymology , Cytosol/enzymology , Glucosyltransferases/chemistry , Phosphorylation , Plant Proteins/chemistry , Plant Stems/enzymology , Protein Processing, Post-Translational
20.
J Hum Genet ; 66(3): 321-325, 2021 Mar.
Article En | MEDLINE | ID: mdl-32908218

Cytosolic PEPCK deficiency (PCKDC) is a rare autosomal recessive inborn error of metabolism, which can present with hypoglycemia, lactic acidosis, and liver failure. It is caused by biallelic pathogenic variants in the PCK1 gene. Only four PCK1 variants have been previously reported in seven patients with PCKDC, and their clinical course of this condition has not been well characterized. Here, we report a Hispanic male with novel biallelic PCK1 variants, p.(Gly430Asp) and p.(His496Gln), who had a unique clinical presentation. He presented with a new onset of growth failure, elevated blood lactate, transaminitis, and abnormal urine metabolites profile, but he has not had documented hypoglycemia. Growth restriction happened due to insufficient caloric intake, and it was improved with nutritional intervention. PCKDC is a manageable disorder and therefore appropriate nutritional and clinical suspicion from typical lab abnormalities which lead to molecular confirmation tests are essential to prevent poor clinical outcomes.


Codon, Nonsense , Energy Intake/genetics , Failure to Thrive/genetics , Growth Disorders/genetics , Intracellular Signaling Peptides and Proteins/genetics , Phosphoenolpyruvate Carboxykinase (GTP)/genetics , Amino Acid Sequence , Birth Weight , Child, Preschool , Citric Acid Cycle , Cytosol/enzymology , Failure to Thrive/blood , Failure to Thrive/urine , Female , Food Preferences , Genotype , Growth Disorders/blood , Growth Disorders/urine , Humans , Infant Food , Intracellular Signaling Peptides and Proteins/deficiency , Male , Microcephaly/genetics , Pedigree , Phosphoenolpyruvate Carboxykinase (GTP)/deficiency , Pregnancy , Pregnancy Complications , Seizures , Sequence Alignment , Sequence Homology, Amino Acid
...